The growth strategies of a global pharmaceutical company: a case study of Aspen Pharmacare Holdings Limited
VM Hodgon, ME Hoque - Problems and perspectives in management, 2017 - ceeol.com
iven the rapid and sustained growth of Aspen over the past decade, the main aim of this
study is to identify and analyze the growth strategies, adopted by Aspen over the period from …
study is to identify and analyze the growth strategies, adopted by Aspen over the period from …
Развитие корпораций в фармацевтической промышленности: тенденции и приоритеты для компаний
МА Литвиненко - Экономический анализ: теория и практика, 2012 - cyberleninka.ru
В статье рассмотрено формирование корпораций и их роль в развитии мировой
фармацевтической промышленности. Проведен анализ структуры, состояния …
фармацевтической промышленности. Проведен анализ структуры, состояния …
Incomplete contracts and industrial organization: a survey
While most researchers in industrial organization agree that the neoclassical, cost-
minimizing, unitary, view of the firm is restrictive, it is still the main object of anlysis in the …
minimizing, unitary, view of the firm is restrictive, it is still the main object of anlysis in the …
[PDF][PDF] Evaluating wholesale and retail mergers in pharmaceuticals
F Bokhari, F Mariuzzo - 2014 - fbokhari.github.io
1. Introduction. The price and quality of service of a drug is the result of the transactions and
efforts of various agents. Manufacturers, importers/traders, wholesalers/distributors, retailers …
efforts of various agents. Manufacturers, importers/traders, wholesalers/distributors, retailers …
Proyecto de Ley Fármacos II”: revisiones generales al funcionamiento del mercado farmacéutico y su regulación
C Díaz Molina - 2020 - repositorio.uchile.cl
El 10 de marzo de 2015 se llevó a cabo el primer trámite constitucional en el Senado
relativo al ingreso del Proyecto de Ley conocido como “Fármacos II”(Boletín 9914-11), a …
relativo al ingreso del Proyecto de Ley conocido como “Fármacos II”(Boletín 9914-11), a …